• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高血压患者的微量白蛋白尿:几种抗高血压药物的作用

Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs.

作者信息

Bianchi S, Bigazzi R, Baldari G, Campese V M

机构信息

U.O. di Nefrologia e Dialisi, Spedali Riuniti, Livorno, Italy.

出版信息

Am J Med. 1992 Nov;93(5):525-8. doi: 10.1016/0002-9343(92)90580-5.

DOI:10.1016/0002-9343(92)90580-5
PMID:1442855
Abstract

PURPOSE

Microalbuminuria can be present in 10% to 40% of patients with essential hypertension and is associated with an increased incidence of cardiovascular events. The effect of commonly used antihypertensive agents on urinary albumin excretion (UAE) has not been well established. The aim of this study was to evaluate the effects of a converting enzyme inhibitor, a calcium channel blocker, a beta blocker, and a diuretic on UAE and on creatinine clearance in patients with mild to moderate hypertension.

PATIENTS AND METHODS

We prospectively measured UAE prior to and 4 and 8 weeks after treatment with enalapril, nitrendipine, atenolol, or a diuretic in 48 patients with essential hypertension and microalbuminuria.

RESULTS

All these agents were equally effective in reducing arterial pressure. However, enalapril but not the other agents significantly decreased UAE.

CONCLUSION

Eight weeks of therapy with enalapril may reduce UAE in patients with mild to moderate essential hypertension, whereas other agents, such as nitrendipine, atenolol, or diuretics, had no measurable effect on UAE. The clinical and prognostic significance of these observations remains to be established.

摘要

目的

微量白蛋白尿可见于10%至40%的原发性高血压患者中,且与心血管事件发生率增加相关。常用抗高血压药物对尿白蛋白排泄(UAE)的影响尚未完全明确。本研究的目的是评估一种转换酶抑制剂、一种钙通道阻滞剂、一种β受体阻滞剂和一种利尿剂对轻度至中度高血压患者UAE及肌酐清除率的影响。

患者与方法

我们前瞻性地测量了48例原发性高血压合并微量白蛋白尿患者在接受依那普利、尼群地平、阿替洛尔或利尿剂治疗前、治疗4周和8周后的UAE。

结果

所有这些药物在降低动脉血压方面同样有效。然而,依那普利可显著降低UAE,而其他药物则无此作用。

结论

依那普利治疗8周可能降低轻度至中度原发性高血压患者的UAE,而其他药物,如尼群地平、阿替洛尔或利尿剂,对UAE无明显影响。这些观察结果的临床及预后意义仍有待确定。

相似文献

1
Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs.原发性高血压患者的微量白蛋白尿:几种抗高血压药物的作用
Am J Med. 1992 Nov;93(5):525-8. doi: 10.1016/0002-9343(92)90580-5.
2
Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker.原发性高血压患者的微量白蛋白尿。血管紧张素转换酶抑制剂和钙通道阻滞剂的作用。
Am J Hypertens. 1991 Apr;4(4 Pt 1):291-6.
3
Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.氢氯噻嗪、阿替洛尔、尼群地平和依那普利在抗高血压治疗中的随机、双盲、多中心比较:HANE研究结果。HANE试验研究组
BMJ. 1997 Jul 19;315(7101):154-9. doi: 10.1136/bmj.315.7101.154.
4
Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension.一种转换酶抑制剂和一种钙通道阻滞剂对原发性高血压患者尿白蛋白排泄的长期影响。
Am J Hypertens. 1993 Feb;6(2):108-13. doi: 10.1093/ajh/6.2.108.
5
Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.依那普利和尼群地平对高血压非胰岛素依赖型糖尿病患者表皮生长因子和白蛋白排泄的影响。
Diabetes Care. 1995 May;18(5):690-3. doi: 10.2337/diacare.18.5.690.
6
Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension.
Hypertens Res. 2000 Nov;23(6):607-12. doi: 10.1291/hypres.23.607.
7
Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.吲达帕胺缓释片/氨氯地平联合治疗糖尿病合并微量白蛋白尿的高血压患者:NESTOR回顾性分析
Am J Hypertens. 2015 Aug;28(8):1064-71. doi: 10.1093/ajh/hpu297. Epub 2015 Jan 26.
8
[Ambulatory continuous 24-hour blood pressure monitoring in the diagnosis and therapy of arterial hypertension and modification by the antihypertensive agents enalapril, metoprolol, mepindolol and nitrendipine].[动态连续24小时血压监测在动脉高血压诊断与治疗中的应用以及依那普利、美托洛尔、美喷妥洛尔和尼群地平对其的影响]
Klin Wochenschr. 1988 Sep 15;66(18):928-39. doi: 10.1007/BF01728957.
9
Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.氢氯噻嗪、阿替洛尔、尼群地平和依那普利在降压治疗中的应用。对左心室肥厚、蛋白尿和代谢参数的影响。HANE试验研究组。
Kidney Int Suppl. 1997 Oct;61:S74-6.
10
Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.尼群地平和依那普利可改善非胰岛素依赖型糖尿病患者的蛋白尿和肾小球滤过率。
Kidney Int Suppl. 1996 Jun;55:S91-3.

引用本文的文献

1
Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.氨氯地平和赖诺普利对原发性高血压患者微量白蛋白尿的影响:一项前瞻性研究。
Indian J Nephrol. 2010 Jan;20(1):15-20. doi: 10.4103/0971-4065.62090.
2
Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?在早期非蛋白尿性肾病中,阻断肾素-血管紧张素系统(RAS)的药物真的具有肾脏保护作用吗?
Curr Hypertens Rep. 2007 Nov;9(5):393-402. doi: 10.1007/s11906-007-0073-8.
3
Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
喹那普利:其在心血管疾病中的药理学及治疗应用的进一步更新
Drugs. 2002;62(2):339-85. doi: 10.2165/00003495-200262020-00009.
4
Treatment of patients with essential hypertension and microalbuminuria.原发性高血压合并微量白蛋白尿患者的治疗。
Drugs. 1997 Dec;54(6):857-66. doi: 10.2165/00003495-199754060-00005.
5
Do calcium channel blockers have renal protective effects?钙通道阻滞剂有肾脏保护作用吗?
Drugs Aging. 1994 Oct;5(4):263-87. doi: 10.2165/00002512-199405040-00004.
6
Choosing the right ACE inhibitor. A guide to selection.选择合适的血管紧张素转换酶抑制剂。选择指南。
Drugs. 1995 Apr;49(4):516-35. doi: 10.2165/00003495-199549040-00003.